BEDDINGFIELD III FREDERICK (President & CEO) reported 1 transaction at SIENNA BIOPHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/3/2019ACC: 0001562180-19-003848
DirectorOfficer· President & CEO
Since Jan 2019
-17.06K
Net shares
Net seller
$13.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
17.06K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−17.06K
Price / share
$0.76
Trade value
$12.97K
% of position
2.0%
7/2/2019
834.66K→817.60K
Total
Net shares
−17.06K
Net value
-$12.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/2/2019 | F · Tax Withholding | −17.06K | $0.76 | $12.97K | 2.0% | 834.66K | 817.60K |
| Total | −17.06K | -$12.97K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned112.61K
Total
112.61K indirect112.61K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 112.61K | Indirect |
| Total | 112.61K | 112.61K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported